CN106588803A - Novel method for preparing 5-acetylisoxazole - Google Patents
Novel method for preparing 5-acetylisoxazole Download PDFInfo
- Publication number
- CN106588803A CN106588803A CN201611005789.5A CN201611005789A CN106588803A CN 106588803 A CN106588803 A CN 106588803A CN 201611005789 A CN201611005789 A CN 201611005789A CN 106588803 A CN106588803 A CN 106588803A
- Authority
- CN
- China
- Prior art keywords
- acid
- reaction
- acetylisoxazole
- compound
- base
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C221/00—Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/64—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of functional groups containing oxygen only in singly bound form
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
本发明公开了一种制备5‑乙酰基异噁唑的方法,该方法从2,3‑丁二酮开始经过羰基保护、烯胺酮化、关环成异噁唑等三步反应。本发明的方法具有原料易得、操作简便、易于放大生产的特点。The invention discloses a method for preparing 5-acetyl isoxazole. The method starts from 2,3-butanedione and undergoes three-step reactions including carbonyl protection, enaminoketolation and ring closure to form isoxazole. The method of the invention has the characteristics of easy-to-obtain raw materials, simple and convenient operation, and easy scale-up production.
Description
技术领域technical field
本发明具体的涉及一种5-乙酰基异噁唑类化合物或其酸式盐的合成工艺。The present invention specifically relates to a synthesis process of 5-acetylisoxazole compounds or acid salts thereof.
背景技术Background technique
异噁唑类化合物是一类重要的五元杂环杂环化合物,作为医药、农药等领域的一种重要有机合成中间体,具有很大的应用价值。同时这类化合物具有很多的生物活性,并且还具有很好的药理学特性,它在降低人类血糖、消除人类的痛、抵抗人类的炎症、杀死有害细菌、控制和减小艾滋病毒的危害等这些方面对人类有大的作用。特别是一些异噁唑衍生物表现出农业化学,具有抑制杂草和土壤细菌生长的活性,所以它在农药和杀虫剂领域也有广泛的应用。异噁唑也被广泛应用于染料,电绝缘油,高温润滑剂,而它的聚合物形式被应用半导体之中。近年来,5-乙酰基异噁唑类化合物在新药研发领域的研究和应用日渐活跃,现有合成方法是从5-异噁唑甲酸出发经过weinreb 酰胺低温反应得到乙酰基(羰基)、合成成本较高,条件苛刻,很难工业化生产。Isoxazole compounds are an important class of five-membered heterocyclic heterocyclic compounds. As an important organic synthesis intermediate in the fields of medicine and pesticides, they have great application value. At the same time, this kind of compound has many biological activities, and also has good pharmacological properties. It can reduce human blood sugar, eliminate human pain, resist human inflammation, kill harmful bacteria, control and reduce the harm of HIV, etc. These aspects have a great effect on human beings. In particular, some isoxazole derivatives exhibit agrochemical properties and have the activity of inhibiting the growth of weeds and soil bacteria, so it is also widely used in the fields of pesticides and insecticides. Isoxazole is also widely used in dyes, electrical insulating oils, high-temperature lubricants, and its polymer form is used in semiconductors. In recent years, the research and application of 5-acetylisoxazole compounds in the field of new drug research and development has become increasingly active. The existing synthesis method is to obtain acetyl (carbonyl) from 5-isoxazole formic acid through low-temperature reaction of weinreb amide, and the synthesis cost High, harsh conditions, difficult to industrialized production.
发明内容Contents of the invention
本发明所要解决的技术问题是为了克服现有的5-乙酰基异噁唑类化合物的制备方法中,不具备通用性,合成成本较高,条件苛刻,很难工业化生产等缺陷,而提供了一种与现有技术完全不同的5-乙酰基异噁唑类化合物及其盐的合成工艺。本发明的合成工艺产率高,操作处理简单,适于工业化生产,且具备通用性。The technical problem to be solved by the present invention is to overcome the shortcomings of the existing 5-acetylisoxazole compound preparation methods, such as lack of versatility, high synthesis cost, harsh conditions, and difficulty in industrialized production, etc., and provide A synthesis process of 5-acetylisoxazole compounds and salts thereof completely different from the prior art. The synthesis process of the invention has high yield, simple operation and treatment, is suitable for industrial production, and has universality.
因此,本发明涉及一种如式III所示的5-乙酰基异噁唑类化合物及其酸式盐的合成工艺,包含下列步骤:Therefore, the present invention relates to a synthesis process of 5-acetylisoxazole compounds and acid salts thereof as shown in formula III, comprising the following steps:
具体实施方式detailed description
下面通过实施例的方式进一步说明本发明,但并不因此将本发明限制在所述的实施例范围之中。下列实施例中未注明具体条件的实施方法,按照常规方法和条件,或按照商品说明书选择。The present invention is further illustrated below by means of examples, but the present invention is not limited to the scope of the examples. For implementation methods that do not indicate specific conditions in the following examples, select according to conventional methods and conditions, or according to the product instructions.
实施例1 化合物1的制备Example 1 Preparation of Compound 1
将(200mmol,17.22g)2,3-丁二酮和(220mmol,32.60g)原甲酸三乙酯搅拌混合均匀,加入1.00g对甲苯磺酸作催化剂室温搅拌18h,取少量反应液用乙酸乙酯萃取薄层色谱点板,原料反应完全,真空除去溶剂。所得产物1,无需纯化直接投下步反应。Stir and mix (200mmol, 17.22g) 2,3-butanedione and (220mmol, 32.60g) triethyl orthoformate evenly, add 1.00g p-toluenesulfonic acid as a catalyst and stir at room temperature for 18h, take a small amount of the reaction solution and wash it with ethyl acetate Ester extraction TLC spot plate, raw material reaction is complete, and the solvent is removed in vacuo. The obtained product 1 was directly put into the next reaction without purification.
实施例2 化合物2的制备Example 2 Preparation of Compound 2
向产物1中加入40ml的N,N-二甲基甲酰胺二甲基缩醛(DMFDMA)在110℃油浴锅中回流24h以上,TLC监控原料反应完全后真空除去溶剂,加入少量乙酸乙酯和石油醚(乙酸乙酯:石油醚=1:9 )50ml静置(先用1:2静置没有晶体结出,后加入部分石油醚),重结晶出黑色片状晶体,抽滤(用石油醚多次冲洗,洗去部分黑色杂质,片状晶体呈金属般银灰色),常温干燥得产物2(1-二甲氨基-4,4-二乙氧基-1-戊烯-3-酮)。两步产率共为55.7%-69.2%。LCMS(m/z): 216(M++H)。Add 40ml of N,N-dimethylformamide dimethyl acetal (DMFDMA) to the product 1, reflux in an oil bath at 110°C for more than 24h, TLC monitors that the reaction of the raw material is complete, remove the solvent in vacuo, and add a small amount of ethyl acetate Put 50ml of petroleum ether (ethyl acetate: petroleum ether = 1:9) and let it stand (first use 1:2 to stand still without crystals, then add some petroleum ether), recrystallize black flaky crystals, and suction filter (use Petroleum ether was washed several times to wash away part of the black impurities, and the flaky crystals were metallic silver-gray), and dried at room temperature to obtain the product 2 (1-dimethylamino-4,4-diethoxy-1-pentene-3- ketone). The two-step yields are 55.7%-69.2% in total. LCMS (m/z): 216 (M + +H).
实施例3 化合物3的制备Example 3 Preparation of compound 3
取产物2 2.15g(10mmol) 和盐酸羟胺0.85 g(12mmol)溶解在30mL甲醇中,升温回流2-3h,TLC监控原料反应完全后,浓缩除去甲醇,加水,加乙酸乙酯萃取(30mL*3),有机相浓缩,柱层析得产物5-乙酰基异噁唑盐酸盐0.98g,产率66.4%。Take 2.15 g (10 mmol) of product 2 and 0.85 g (12 mmol) of hydroxylamine hydrochloride and dissolve them in 30 mL of methanol, raise the temperature and reflux for 2-3 hours. After the reaction of the raw materials is monitored by TLC, concentrate to remove methanol, add water, and extract with ethyl acetate (30 mL*3 ), the organic phase was concentrated, and column chromatography gave 0.98 g of the product 5-acetylisoxazole hydrochloride, with a yield of 66.4%.
LCMS(m/z):111(M++H) 1H NMR (600 MHz, DMSO-d 6) δ 11.98 (s, 1H), 8.63(d, J = 1.9 Hz, 1H), 6.79 (d, J = 1.9 Hz,1H), 2.17 (s, 3H)。LCMS(m/z):111(M + +H) 1 H NMR (600 MHz, DMSO- d 6 ) δ 11.98 (s, 1H), 8.63(d, J = 1.9 Hz, 1H), 6.79 (d, J = 1.9 Hz,1H), 2.17 (s, 3H).
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611005789.5A CN106588803A (en) | 2016-11-16 | 2016-11-16 | Novel method for preparing 5-acetylisoxazole |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611005789.5A CN106588803A (en) | 2016-11-16 | 2016-11-16 | Novel method for preparing 5-acetylisoxazole |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106588803A true CN106588803A (en) | 2017-04-26 |
Family
ID=58591084
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611005789.5A Pending CN106588803A (en) | 2016-11-16 | 2016-11-16 | Novel method for preparing 5-acetylisoxazole |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106588803A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108484516A (en) * | 2018-05-14 | 2018-09-04 | 四川尚锐生物医药有限公司 | A kind of SC 69124 sodium impurity and preparation method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1950359A (en) * | 2004-05-12 | 2007-04-18 | 安万特药物公司 | Substantially pure 2-{[2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carbonyl]-amino}-3-(phenylpyridin-2-yl-amino)-propionic acid as an IKB kinase inhibitor |
CN1314683C (en) * | 2002-08-17 | 2007-05-09 | 塞诺菲-安万特德国有限公司 | Indole derivatives or benzimidazole derivatives for modulating IKB kinase |
CN102775365A (en) * | 2011-05-10 | 2012-11-14 | 无锡立诺康医药科技有限公司 | Synthesis process for 5-amino-substitued-isoxazole compound or acid salt thereof |
CN102884048A (en) * | 2009-12-22 | 2013-01-16 | Msd欧斯股份有限公司 | Amino-heteroaryl derivatives as HCN blockers |
-
2016
- 2016-11-16 CN CN201611005789.5A patent/CN106588803A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1314683C (en) * | 2002-08-17 | 2007-05-09 | 塞诺菲-安万特德国有限公司 | Indole derivatives or benzimidazole derivatives for modulating IKB kinase |
CN1950359A (en) * | 2004-05-12 | 2007-04-18 | 安万特药物公司 | Substantially pure 2-{[2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carbonyl]-amino}-3-(phenylpyridin-2-yl-amino)-propionic acid as an IKB kinase inhibitor |
CN102884048A (en) * | 2009-12-22 | 2013-01-16 | Msd欧斯股份有限公司 | Amino-heteroaryl derivatives as HCN blockers |
CN102775365A (en) * | 2011-05-10 | 2012-11-14 | 无锡立诺康医药科技有限公司 | Synthesis process for 5-amino-substitued-isoxazole compound or acid salt thereof |
Non-Patent Citations (2)
Title |
---|
ANTONIO SALGADO,等: "Synthesis of 1-alkyl-2-methylazetidin-3-ones and 1-alkyl-2-methylazetidin-3-ols", 《TETRAHEDRON》 * |
GUOLAN DOU,等: "Clean and Efficient Synthesis of Isoxazole Derivatives in Aqueous Media", 《MOLECULES》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108484516A (en) * | 2018-05-14 | 2018-09-04 | 四川尚锐生物医药有限公司 | A kind of SC 69124 sodium impurity and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111592533B (en) | 1,2,4-Oxadiazole bipyridine substituted benzamide compounds and preparation method and application thereof | |
CN102432523B (en) | Method for synthesizing 3-hydroxy-3-arylindole-2-one derivative | |
CN106431969B (en) | A kind of method for preparing 2- methyl -4- formaldoxime yl benzoic acid methyl esters | |
CN104829590B (en) | Method for purifying trelagliptin | |
CN106588803A (en) | Novel method for preparing 5-acetylisoxazole | |
CN103351410A (en) | 1-ferrocenyl-3-[(N-(2-substituted benzimidazolyl)]-2-propylene-1-ketone and preparation method and application thereof | |
CN103880776B (en) | A kind of method preparing 2-amino-5-alkyl-1,3,4-thiadiazoles | |
CN102464699A (en) | A kind of preparation method of sodium carbenate | |
CN106008653B (en) | Enoxolone acylhydrazone and its preparation method and application | |
CN103145666B (en) | 4-substituted alpha-pyrone derivative as well as preparation method and application thereof | |
CN110372774A (en) | The alpha-acyloxy amides dipeptides analog derivative and synthetic method that isoindolone replaces | |
CN104311446A (en) | Method for catalysis synthesis of (Z)-2-acetylamino methyl cinnamate through DCC/DMAP | |
CN105399683B (en) | Benzimidazole derivatives and process for preparing the same | |
CN113072514A (en) | Preparation method of cycleanine and intermediate thereof | |
CN102924265B (en) | The method of asymmetric synthesis of (+)-Salvianic acidA | |
CN103570547B (en) | A kind of Industrialized synthesis method of Salvianic acidA isopropyl ester | |
CN109970643A (en) | A kind of green synthesis method of tetrahydroacridine compound under the promotion of iodine anion | |
CN108299302A (en) | A kind of new method preparing 3- acetyl pyrazoles | |
CN104761568B (en) | One class Fourth Ring Nai Bing oxazole derivatives and preparation method thereof | |
CN103936619A (en) | Preparation method and application of pyruvate acetal p-nitrobenzoylhydrazone | |
CN103570546B (en) | A kind of Industrialized synthesis method of danshensu norbornene ester | |
CN116375656B (en) | A kind of metconazole metabolite and preparation method thereof | |
CN103254112A (en) | Bisindole alkaloid derivative, and synthesis method and application thereof | |
CN100500650C (en) | A kind of chemical synthesis method of nitrile substance | |
CN108147971A (en) | A kind of preparation method of adjacent nitro P-nethoxyaniline |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170426 |
|
RJ01 | Rejection of invention patent application after publication |